SCHEMBL14007486

SCHEMBL14007486

Oc1ccc2cc3c(cc2c1)CCC3

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.50
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
PRKCI P41743 1/20 0.47
ESR1 P03372 6/20 0.46
ESR2 Q92731 6/20 0.46
CYP3A4 P08684 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
HIF1A Q16665 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ABL1 P00519 1/20 0.43
ABCB1 P08183 1/20 0.43
BCR P11274 1/20 0.43
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
HSD17B1 P14061 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL281714 0.78 MAOA (0.57) MAOAMAOBPRKCIDRD2DRD1
SCHEMBL29442640 0.78 MAOA (0.57) MAOAMAOBPRKCIDRD2DRD1
SCHEMBL3451975 0.77 CYP1A2 (0.78) CYP1A2ESR1ESR2CYP3A4ALOX15
SCHEMBL29405718 0.77 CYP1A2 (0.68) CYP1A2ESR1ESR2CYP3A4ALOX15
SCHEMBL392290 0.77 CYP1A2 (0.68) CYP1A2ESR1ESR2CYP3A4ALOX15
SCHEMBL29973107 0.77 CYP1A2 (0.68) CYP1A2ESR1ESR2CYP3A4ALOX15
SCHEMBL755928 0.77 CYP1A2 (0.68) CYP1A2ESR1ESR2CYP3A4ALOX15
SCHEMBL627219 0.77 CYP1A2 (0.77) CYP1A2ESR1ESR2CYP3A4ALOX15
SCHEMBL69484 0.77 CYP1A2 (0.77) CYP1A2ESR1ESR2CYP3A4ALOX15
SCHEMBL29364786 0.77 CYP1A2 (0.77) CYP1A2ESR1ESR2CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280935-A1 Process to Prepare Camptothecin Derivatives CHATHAM BIOTEC, LIMITED (CA) 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280935-A1 Process to Prepare Camptothecin Derivatives TOP1, TOP2A, SI CYP1A2 214/4885MAOA 3244/4885MAOB 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.